The EBMT

Have you seen this publication? 👀 📰 Patient-reported outcomes in HSCT for autoimmune diseases: Considerations on behalf of the EBMT ADWP, PAC, and Nurses Group Discover more ➡ https://lnkd.in/dpwxu56D Authors 👥 Alexander Tobias, Noëlle Tassy, Ariadna Sarrà Domenech, Ellen Kramer, Helen Jessop, Michelle Kenyon, Basil Sharrack, Riccardo Saccardi, Natasha Bolanos, Professor JOHN SNOWDEN and Raffaella Greco #cellulartherapy #autoimmunedisease #transplantation #HCT #HSCT #patientcare

📣 Open–minded approach, commitment to #JACIE, team spirit and good interpersonal skills wanted! 🔎 The JACIE Inspector Committee (JIC) is looking to recruit new members. 👥 🏥 Inspectors working in accredited centres interested in this fantastic opportunity: make sure to submit your application by 19 July! 📅 ➡ https://lnkd.in/d8EQq7Zn More about the Inspector Committee ➡ https://lnkd.in/dRScJN_b

#Nurse, are you looking for a new, meaningful #CareerOpportunity? 🚀 The EBMT Nurses Group is looking for the following representatives to join #EBMT as a working party (WP) nurse! Discover more and apply before Friday 26 July 📅 ➡️ https://lnkd.in/evzzjVe 💡 The purpose of the working party nurse is to promote, drive, manage nursing research activity and nursing education within the Working Party under the leadership and supervision of the WP lead nurse, and in collaboration with the EBMT Nurses Group Board, Research and Scientific committees.

📣 Present your work in the field of #CellularTherapies and #lymphoma, and win a Travel Grant to one of our upcoming Educational Events in Italy, Netherlands or Spain! ✈ 📅 Mark up the approaching Case Submission deadlines on 14 July and 4 August, and take a closer look at the 📰 Case Report Topics on ebmt.org/events: 🔬 Immunology and Cellular Therapies in #AutoimmuneDiseases ➡ https://lnkd.in/dsv26--y ⚕ #Lymphoma Working Party Educational Course ➡ https://lnkd.in/dSngjGEn 🏥 Complications post CAR-T #CellTherapy in Paediatric and Adult Patients - 👩⚕️ #Nurse's track available! ➡ https://lnkd.in/d9vC6Mvh See you soon at our next events! 👋

💡 Check out this recent publication in Bone Marrow Transplantation journal! 📰 Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the Acute Leukemia Working Party (EBMT) Discover more ➡ https://lnkd.in/dmJE7Xwq Authors 👥 Gesine Bug, myriam LABOPIN, Alexander Kulagin, Blaise Didier, Anna Maria Raiola, Jan Vydra, simona sica, Mi Kwon, Lucía López-Corral, Stefania Bramanti, Peter Von dem Borne, Maija Itälä-Remes, Massimo Martino, Yener Koc, Eolia Brissot, Sebastian Giebel, Arnon Nagler, Fabio Ciceri & Mohamad Mohty #transplantation #leukaemia #HCT #scientificarticle

❔ 📰 How risky is a second allogeneic stem cell transplantation? Take a look at this insightful, recently published article ➡ https://lnkd.in/dZkuHxB8 Authors 👥 Olaf Penack, Mouad A., Christophe Peczynski, jakob passweg, William Boreland, Nicolaus Kröger, Robert Zeiser, Fabio Ciceri, Thomas Schroeder, Peter Dreger, jakob passweg, Johannes Schetelig, Matthias Stelljes, Igor Wolfgang Blau, Georg-Nikolaus Franke, Dr. Katarina Riesner, Helene Schoemans, Ivan Moiseev & Zinaida Peric #haematology #HCT #scientificarticle #leukaemia

🔎 Take a look at June's Clinical Case of the Month 📋 Refractory Autoimmune Haemolytic Anaemia (AIHA) after Allogeneic Stem Cell Transplantation: stabilisation with the use of rituximab and bortezomib. Discover more ➡ https://lnkd.in/dUqUdAB6 Submitted by: Jose María Aspa Cilleruelo Physicians' expert perspective: Elisa Roldan-Galvan & Professor JOHN SNOWDEN

FREE SUBSCRIPTION FOR RESIDENT DOCTORS!!! 📣 📣 CAR-T therapies are REVOLUTIONIZING cancer treatment! Join us in Malaga on Nov 15-16 for an educational course covering EVERYTHING you need to know about CAR-T complications! #CARTMalaga #CancerTreatment #MedicalBreakthroughs The EBMT

"But it worked" Dr. Carl June, the "father of CAR-T cell therapy", in his own words to The Medicine Maker upon receiving the Advanced Therapies Lifetime Achievement Award 🏆 "No one could have predicted what has happened in CAR T – for many reasons. For one thing, it actually worked a lot better in our initial trials in humans than it had worked in mice. [] Also, back in the 1990s, there were only about five labs working on CAR T cells. There was no pharmaceutical industry involvement back then, and for the academics (including my own lab) that were working on the topic, it was more of an academic thought experiment: Could you redirect a T cell and use it to treat cancer? We weren’t necessarily thinking it would or could ever be commercialized, but it worked. Back then, there was no cell therapy industry – but now there is. And the statistics are amazing." University of Pennsylvania School of Medicine #celltherapy #curecancer #legend 👇 Link ▶ https://lnkd.in/ejxvyeBX

🔎 Are you looking to expand your expertise in innovative Cellular Therapies and Immunology in Autoimmune Diseases? ⚕ 🔬 If yes, this upcoming joint Educational Meeting is for you! 👩⚕️ Note that the Case Submission will close by the end of the week, so present your work by 📅 30 June to win a Travel Grant to Milan! ✈ The Case Topics include: 📄 Pathophysiology and novel therapeutic targets 📄 Novel CAR technologies and indications 📄 Late complications after cellular therapies Discover more and submit your case today ➡ https://lnkd.in/dsv26--y